COMMUNIQUÉS West-GlobeNewswire

Nu-Med Plus, Inc. Advances Blood and Plasma Transfusion Technology with New Patent
14/11/2018
Nu-Med Plus’ Proprietary Technology Aims to Increase Longevity and Safety of Banked Blood Supply and Reduce Side Effects of Blood Transfusions SALT LAKE CITY, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc . (OTCQB [...]
FRDJ Canada et Diabète Canada illuminent de bleu la province de la Colombie-Britannique pour sensibiliser à la cause lors de la Journée mondiale du diabète le 14 novembre
14/11/2018
VANCOUVER, British Columbia, 14 nov. 2018 (GLOBE NEWSWIRE) -- Diabète Canada et FRDJ Canada font équipe pour illuminer la province de bleu en célébration de la Journée mondiale du diabète le 14 novembre. Novembre est le [...]
JDRF Canada and Diabetes Canada light the province of BC blue on World Diabetes Day Nov. 14th to raise awareness
14/11/2018
VANCOUVER, British Columbia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Diabetes Canada and JDRF Canada are working together to light the province blue in celebration of World Diabetes Day on November 14th. November is National [...]
Virbac: Availability of the quarterly financial information as of September 30, 2018
14/11/2018
Virbac: Availability of the quarterly financial information as of September 30, 2018 Public release - November 14, 2018 The quarterly financial information as of September 30, 2018 is available: · on our website: [...]
Virbac : Mise à disposition de l'information financière trimestrielle au 30 septembre 2018
14/11/2018
Virbac : Mise à disposition de l'information financière trimestrielle au 30 septembre 2018 Communiqué diffusé le 14 novembre 2018 L'information financière trimestrielle au 30 septembre 2018 est disponible : · sur notre [...]
Genmab Announces Financial Results for the First Nine Months of 2018
14/11/2018
November 14, 2018; Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2018 Highlights USD 1,441 million in net sales of DARZALEX ® (daratumumab), resulting in royalty income of DKK 1,111 [...]
On Transactions Under Regulation No 596/2014
14/11/2018
Additional information available in the document attached. Information prepared by: Inga Krukle Member of the Management Board JSC Olainfarm Phone: +371 28698449 E-mail: inga.krukle@olainfarm.com Attachment [...]
On Transactions Under Regulation No 596/2014
14/11/2018
Additional information available in the document attached. Information prepared by: Inga Krukle Member of the Management Board JSC Olainfarm Phone: +371 28698449 E-mail: inga.krukle@olainfarm.com Attachment [...]
Webinar to Highlight Technology Underlying Precipio’s ICE COLD-PCR on November 20, 2018
14/11/2018
Current Status, Existing and Future Applications of COLD-PCR for Cancer and Prenatal Diagnosis to Be Presented NEW HAVEN, Conn., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: [...]
About acquisition of significant shareholding
14/11/2018
On November 12, 2018, JSC Olainfarm received a notification from shareholder OLFIM OÜ on increased shareholding up till 7.79% from share capital with voting rights, since the November 6, 2018. The announcement of OLFIM [...]
Change in significant shareholding
14/11/2018
On November 12, 2018, JSC "Olainfarm" received a notification by shareholder Irina Maligina stating that since November 6, 2018, the form of participation of I.Maligina has changed: from direct to indirect. The notice [...]
Phoenix Life Sciences Receives Import Certificate for Cannabis Diabetes Drug from the Republic of Vanuatu
14/11/2018
DENVER, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTCMarkets: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it has received an [...]
Nemaura Medical to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
14/11/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by people with diabetes [...]
Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
14/11/2018
Highlights Include FDA Approval of Phase 2 On-Ambulance Clinical Trial for Treatment of Stroke and Appointment of New Chief Financial Officer CHARLOTTESVILLE, Va., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Diffusion [...]
Chiesi Salutes Neonatal Intensive Care Unit Staff in Honor of Prematurity Awareness Month®
14/11/2018
In partnership with March of Dimes, video featuring parents of preterm infants and NICU staff raises awareness of prematurity through first-hand accounts from the NICU CARY, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) -- In [...]
Mateon Therapeutics Reports Third Quarter 2018 Financial Results
14/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today [...]
Virginia Premier Expands Engagement With the Inovalon One® Platform
14/11/2018
Leading Health Plan Expands Use of Inovalon Platform to Add Automated Clinical Data Extraction and Natural Language Processing Toolsets BOWIE, Md., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading [...]
Teladoc Health, USC Collaborate for Groundbreaking Study of Virtual Care Prescribing
14/11/2018
Researchers take telehealth quality initiatives to the next level by examining antibiotic prescribing influences PURCHASE, NY, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual [...]
Advanced Proteome Therapeutics Reports Positive Results and Advances Collaboration with Heidelberg Pharma
14/11/2018
VANCOUVER, British Columbia , Nov. 14, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) , is pleased to announce very positive results from animal [...]

Pages